Sorafenib in Advanced Hepatocellular Carcinoma
2008 · New England Journal of Medicine · 13K citations
https://doi.org/10.1056/nejmoa0708857
A
Armando Santoro
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.8K
Papers
77.2K
Citations
121
h-index
685
i10-index
Armando Santoro is an academic researcher from Humanitas University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Lung Cancer Treatments and Mutations & Chronic Lymphocytic Leukemia Research. The author has an h-index of 121, co-authored 1568 publications.
ORCID: 0000-0003-1709-9492Papers by this author
worksCetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 · New England Journal of Medicine · 5,033 citations
https://doi.org/10.1056/nejmoa033025
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
2021 · Annals of Oncology · 702 citations
https://doi.org/10.1016/j.annonc.2021.05.801
Increased <i>MET</i> Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients
2009 · Journal of Clinical Oncology · 550 citations
https://doi.org/10.1200/jco.2008.19.1635
A Randomized Study of Lung Cancer Screening with Spiral Computed Tomography
2009 · American Journal of Respiratory and Critical Care Medicine · 378 citations
https://doi.org/10.1164/rccm.200901-0076oc
Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
1986 · Journal of Clinical Oncology · 312 citations
https://doi.org/10.1200/jco.1986.4.6.830
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat